BsUFA III Meeting Improvements To Cut Requests, Improve Biosimilar Development Efficiency

 
• By Derrick Gingery
  
Team efficiency
Quicker, targeted advice on from the FDA is expected to help speed biosimilar development. • Source: Alamy
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Biosimilars & Generics